This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Negri, M.-C.
Right arrow Articles by Baquero, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Negri, M.-C.
Right arrow Articles by Baquero, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2002, p. 528-530, Vol. 46, No. 2
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.2.528-530.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Very Low Cefotaxime Concentrations Select for Hypermutable Streptococcus pneumoniae Populations

María-Cristina Negri, María-Isabel Morosini, María-Rosario Baquero, Rosa del Campo, Jesús Blázquez, and Fernando Baquero*

Servicio de Microbiología, Hospital Ramón y Cajal, Madrid, Spain

Received 9 July 2001/ Returned for modification 15 September 2001/ Accepted 29 October 2001

A mixed culture of an hypermutable hexA Streptococcus pneumoniae mutant strain and its hexA+ isogenic ancestor was challenged with low cefotaxime concentrations. Despite identical original cefotaxime MICs, the hexA mutant population was significantly selected at very low concentrations, and all of the tested selected variants harbored the Thr550->Ala mutation in pbp2x. Since cefotaxime selects hypermutators, the risk of secondary acquisition of antibiotic resistance is increased; as expected, the cefotaxime-resistant mutants had a mutation frequency 10 times higher in response to to ciprofloxacin. The present study presents a model (not necessarily reflecting the clinical setting) illustrating the risk of selection of mutators in the evolution of multiple resistance.


* Corresponding author. Mailing address: Departmento de Microbiología, Hospital Ramón y Cajal, Ctra. de Colmenar, Km 9,1. 28034, Madrid, Spain. Phone number: 34-91-3368330. Fax: 34-91-3368809. Email: fbaquero{at}hrc.insalud.es.


Antimicrobial Agents and Chemotherapy, February 2002, p. 528-530, Vol. 46, No. 2
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.2.528-530.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Hanage, W. P., Fraser, C., Tang, J., Connor, T. R., Corander, J. (2009). Hyper-Recombination, Diversity, and Antibiotic Resistance in Pneumococcus. Science 324: 1454-1457 [Abstract] [Full Text]  
  • Zerfass, I., Hakenbeck, R., Denapaite, D. (2009). An Important Site in PBP2x of Penicillin-Resistant Clinical Isolates of Streptococcus pneumoniae: Mutational Analysis of Thr338. Antimicrob. Agents Chemother. 53: 1107-1115 [Abstract] [Full Text]  
  • Gould, C. V., Sniegowski, P. D., Shchepetov, M., Metlay, J. P., Weiser, J. N. (2007). Identifying Mutator Phenotypes among Fluoroquinolone-Resistant Strains of Streptococcus pneumoniae Using Fluctuation Analysis. Antimicrob. Agents Chemother. 51: 3225-3229 [Abstract] [Full Text]  
  • Kang, J. M., Iovine, N. M., Blaser, M. J. (2006). A paradigm for direct stress-induced mutation in prokaryotes. FASEB J. 20: 2476-2485 [Abstract] [Full Text]  
  • Henderson-Begg, S. K., Livermore, D. M., Hall, L. M. C. (2006). Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae. J Antimicrob Chemother 57: 849-854 [Abstract] [Full Text]  
  • Jewell, N. A., Chen, R., Raices, R., Mansky, L. M. (2003). Nucleoside reverse transcriptase inhibitors and HIV mutagenesis. J Antimicrob Chemother 52: 547-550 [Full Text]  
  • Li, B., Tsui, H.-C. T., LeClerc, J. E., Dey, M., Winkler, M. E., Cebula, T. A. (2003). Molecular analysis of mutS expression and mutation in natural isolates of pathogenic Escherichia coli. Microbiology 149: 1323-1331 [Abstract] [Full Text]  
  • Morosini, M.-I., Baquero, M.-R., Sanchez-Romero, J. M., Negri, M.-C., Galan, J.-C., del Campo, R., Perez-Diaz, J. C., Baquero, F. (2003). Frequency of Mutation to Rifampin Resistance in Streptococcus pneumoniae Clinical Strains: hexA and hexB Polymorphisms Do Not Account for Hypermutation. Antimicrob. Agents Chemother. 47: 1464-1467 [Abstract] [Full Text]